北美血浆分离市场预测至 2028 年 - COVID-19 影响和按产品（免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品）、应用（神经病学、免疫学、血液学、重症监护、肺病学和其他应用程序）和最终用户（医院和诊所、临床研究实验室和学术机构）
市场介绍
北美血浆分离市场分为美国、加拿大、和墨西哥。市场的增长广泛归因于凝血因子浓缩物、凝血因子浓缩物和其他血浆衍生产品的日益增长的应用，用于治疗各种血液疾病，如血友病 A、血友病 B。此外，加拿大市场的增长预计将由于以下因素而增长：多发性硬化症和其他神经系统疾病的患病率不断增加。此外，在墨西哥，由于人们对血液及相关疾病、免疫疾病的认识不断提高，以及对治疗慢性疾病的血浆衍生疗法的认识不断提高，预计该市场将会增长。
COVID-19 大流行给该地区的医疗机构带来了前所未有的运营和临床挑战。此外，重点从慢性病和紊乱治疗转向COVID-19诊断和治疗设备正在导致市场增长在一定程度上下降。尽管尚未批准针对COVID-19的具体药物疗法，但根据多项临床试验的结果，恢复期血浆疗法有望提高COVID-19患者的生存率。例如，在北美，食品药品监督管理局已批准恢复期血浆的紧急使用授权，用于治疗和护理 COVID-19 患者。 EUA，即紧急使用授权，已授权在美国分发恢复期血浆用于治疗疑似和确诊的 COVID-19 患者。因此，紧急使用恢复期血浆治疗 COVID-19 患者正在对市场增长产生积极影响。
此外，由于 COVID-19 的爆发，献血量总体下降，最终影响了血液和血浆衍生产品。献血量的减少影响了需要血浆制品或输血的外科手术和其他慢性疾病的治疗。因此，COVID-19 的爆发对北美的血浆分离市场产生了负面影响。然而，随着疫苗接种活动的开始和传播率的下降，从长远来看，医疗保健系统将恢复正常。反过来，预计这将增加对用于治疗各种疾病的血液和血浆衍生产品的需求。
;
市场概况与动态
北美血浆分离市场预计将从2021年的94.8491亿美元增长到2028年的147.409亿美元；预计 2021 年至 2028 年复合年增长率为 6.5%。与代谢组学相关的市场参与者正在积极探索可能的创新技术，以促进研究人员和医疗保健，因为血浆中含有治疗疾病的基本成分，例如抗体。目前正在开展各种研究，探讨血浆在治疗传统方法难以治愈的疾病方面的可能应用。此外，人们对献血优势和血浆应用的认识不断提高，预计将为市场开辟新的空间。
主要细分市场
北方美国血浆分离市场按产品、应用、最终用户和国家细分。北美血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。北美血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年，神经病学领域可能会占据最大的市场份额。北美血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年，医院和诊所部门可能会占据最大的市场份额。根据国家/地区，北美血浆分离市场分为美国、加拿大和墨西哥。 2020 年，美国占据最大市场份额。
主要来源和上市公司
准备这份北美血浆分离市场报告时提到的一些主要的一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV)；生物制品实验室有限公司； CSL有限公司；格里福尔斯，SA； Kedrion SpA；奥克塔制药公司；和 SK 等离子。
购买报告的理由
- 了解北美血浆分馏市场格局并确定最有可能保证强劲的细分市场回报。
- 了解北美血浆分馏市场不断变化的竞争格局，保持竞争优势。
- 通过识别最有可能销售前景的细分市场，有效规划北美血浆分馏市场的并购和合作交易。
- 帮助通过敏锐和全面的分析做出明智的业务决策北美血浆分馏市场各个细分市场的市场表现。
- 获取北美地区 2021-2028 年各个细分市场的市场收入预测。
- 获取北美地区各个细分市场的市场收入预测。 span>
北美血浆分馏市场细分
北美血浆分馏市场 - 按产品
- 免疫球蛋白
- 静脉注射免疫球蛋白（IVIG）
- 皮下注射免疫球蛋白（ SCIG)
- 白蛋白
- 凝血因子浓缩物
- 蛋白酶抑制剂
- 其他
北美血浆分馏市场 - 按应用
- 神经病学
- 免疫学
- 血液学
- 重症监护
- 肺病学
- 其他
北美血浆分馏市场- 按最终用户
- 医院和诊所
- 临床研究实验室
- 学术机构
北美血浆分馏市场 - 按国家/地区
- 美国
- 加拿大
- < span>墨西哥
北美血浆分馏市场 - 公司简介
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- CSL Limited
- Grifols，SA
- Kedrion SpA
- Octapharma AG
- SK 等离子
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Plasma Fractionation Market – By Product
1.3.2 North America Plasma Fractionation Market – By Application
1.3.3 North America Plasma Fractionation Market – By End User
1.3.4 North America Plasma Fractionation Market – By Country
2. North America Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Uses of Plasma Therapy
5.1.2 New Developments Owing to Active Participation of the Market Players
5.2 Market Restraints
5.2.1 Presence of Non-Plasma Substitutes
5.3 Future Trends
5.3.1 Plasma Therapy Being Used for Treating Novel Diseases
5.4 Impact Analysis
6. Plasma Fractionation Market – North America Analysis
6.1 North America Plasma Fractionation Market Revenue Forecast and Analysis
7. North America Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 North America Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. North America Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 North America Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 North America Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 North America: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 US Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 US Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 US Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.5 US Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.2 Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Canada Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 Canada Plasma Fractionation Market, by immunoglobulin type– Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Canada Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.5 Canada Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.3 Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 Mexico Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 Mexico Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 Mexico Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.5 Mexico Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Plasma Fractionation Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Octapharma AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Kedrion S.p.A
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CSL Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Grifols, S.A.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio Products Laboratory Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bharat Serums and Vaccines Limited (BSV)
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SK Plasma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. US Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Plasma Fractionation Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Plasma Fractionation Market, by immunoglobulin type - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Plasma Fractionation Market, By Application - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic developments done by Companies
Table 15. Glossary of Terms, North America Plasma Fractionation Market
LIST OF FIGURES
Figure 1. North America Plasma Fractionation Market Segmentation
Figure 2. North America Plasma Fractionation Market Segmentation, By Country
Figure 3. North America Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in North America Plasma Fractionation Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to North America Plasma Fractionation Market
Figure 8. North America Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. North America Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. North America Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. North America Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. North America Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. North America Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. North America Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. North America Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. North America Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. North America Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. North America Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. North America Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. North America Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. North America Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. North America Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. North America Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. North America: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
Figure 34. Growth Strategies Followed by Major Market Players (%)
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution